Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001685720-26-000003

Director sold 17,202 shares at an average $8.40 ($144,453)

  • Director acquired 25,344 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Zoon Kathryn C · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-04-30 Grant or award : show line 1 in the form 10b5-1 +25,344 97,143 D
2026-05-01 Sale : show line 2 in the form 10b5-1 −16,145 $8.36 $134,972 80,998 D
2026-05-01 Sale : show line 3 in the form 10b5-1 −1,057 $8.97 $9,481 79,941 D
Open-market sales · 17,202 sh · avg $8.40 · $144,453

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-04-30 Grant or award : show line 4 in the form 10b5-1 Stock Option (Right to Buy) +11,296 11,296 D
Loading xslF345X06/wk-form4_1777930077.xml…